DOT Name |
Interferon alpha-21 (IFNA21)
|
Synonyms |
IFN-alpha-21; Interferon alpha-F; LeIF F |
Gene Name |
IFNA21
|
UniProt ID |
|
3D Structure |
|
Pfam ID |
|
Sequence |
MALSFSLLMAVLVLSYKSICSLGCDLPQTHSLGNRRALILLAQMGRISPFSCLKDRHDFG FPQEEFDGNQFQKAQAISVLHEMIQQTFNLFSTKDSSATWEQSLLEKFSTELNQQLNDLE ACVIQEVGVEETPLMNVDSILAVKKYFQRITLYLTEKKYSPCAWEVVRAEIMRSFSLSKI FQERLRRKE
|
Function |
Produced by macrophages, IFN-alpha have antiviral activities. Interferon stimulates the production of two enzymes: a protein kinase and an oligoadenylate synthetase. |
KEGG Pathway |
- Cytokine-cytokine receptor interaction (hsa04060 )
- PI3K-Akt sig.ling pathway (hsa04151 )
- Necroptosis (hsa04217 )
- Toll-like receptor sig.ling pathway (hsa04620 )
- NOD-like receptor sig.ling pathway (hsa04621 )
- RIG-I-like receptor sig.ling pathway (hsa04622 )
- Cytosolic D.-sensing pathway (hsa04623 )
- JAK-STAT sig.ling pathway (hsa04630 )
- .tural killer cell mediated cytotoxicity (hsa04650 )
- Alcoholic liver disease (hsa04936 )
- Tuberculosis (hsa05152 )
- Hepatitis C (hsa05160 )
- Hepatitis B (hsa05161 )
- Measles (hsa05162 )
- Human cytomegalovirus infection (hsa05163 )
- Influenza A (hsa05164 )
- Human papillomavirus infection (hsa05165 )
- Kaposi sarcoma-associated herpesvirus infection (hsa05167 )
- Herpes simplex virus 1 infection (hsa05168 )
- Epstein-Barr virus infection (hsa05169 )
- Human immunodeficiency virus 1 infection (hsa05170 )
- Coro.virus disease - COVID-19 (hsa05171 )
- Pathways in cancer (hsa05200 )
- Autoimmune thyroid disease (hsa05320 )
- Lipid and atherosclerosis (hsa05417 )
|
Reactome Pathway |
- Regulation of IFNA/IFNB signaling (R-HSA-912694 )
- TRAF6 mediated IRF7 activation (R-HSA-933541 )
- SARS-CoV-2 activates/modulates innate and adaptive immune responses (R-HSA-9705671 )
- Factors involved in megakaryocyte development and platelet production (R-HSA-983231 )
- Interferon alpha/beta signaling (R-HSA-909733 )
|
|
|
|
|
|
|